https://scholars.lib.ntu.edu.tw/handle/123456789/641588
標題: | Glofitamab as a salvage treatment for B-cell lymphomas in the real world: A multicenter study in Taiwan | 作者: | Hsu, Ya-Ting SHANG-JU WU Kao, Hsiao-Wen Hsiao, Sheng-Yen Liao, Chun-Kai Chen, Tsai-Yun Wang, Ming-Chung |
關鍵字: | B-cell lymphoma; bispecific antibody; glofitamab; real-world data | 公開日期: | 2-二月-2024 | 來源出版物: | Cancer | 摘要: | Glofitamab is a bispecific antibody with promise for treating relapsed/refractory B-cell lymphoma according to a phase 1/2 clinical trial. This study examined its real-world effectiveness. |
URI: | https://www.scopus.com/record/display.uri?eid=2-s2.0-85184243118&doi=10.1002%2fcncr.35217&origin=inward&txGid=5d8b708be292a0f79ab780b99a1253b5 https://scholars.lib.ntu.edu.tw/handle/123456789/641588 |
ISSN: | 0008543X | DOI: | 10.1002/cncr.35217 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。